![]() |
![]() |
Legal status
Patent expired
(51) | INT.CL. | A61K 31/44 | (2006.01) |
A61K 31/535 | (2006.01) | ||
A61K 31/65 | (2006.01) | ||
A61K 31/435 | (2006.01) | ||
A61K 31/505 | (2006.01) | ||
A61K 31/47 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 2305255 |
(13) | Kind of document | T |
(96) | European patent application number | 10183659.1 |
Date of filing the European patent application | 2002-12-03 | |
(97) | Date of publication of the European application | 2011-04-06 |
(45) | Date of publication and mention of the grant of the patent | 2012-08-22 |
(46) | Date of publication of the claims translation | 2012-11-26 |
(30) | Number | Date | Country code |
334609 P | 2001-12-03 | US |
(72) |
Trail, Pamela, US
Vincent, Patrick, US
Zhai, Yifan, US
Carter, Christopher A., US
Gibson, Neil, US
Hibner, Barbara, US
Humphrey, Rachel W., US
Dumas, Jacques, US
Riedl, Bernd, DE
Khire, Uday, US
Lowinger, Thimothy B., US
Scott, William J., US
Smith, Roger A., US
Wood, Jill E., US
Monahan, Mary-Katherine, US
Natero, Reina, US
Renick, Joel, US
Sibley, Robert N., US
|
(73) |
Bayer HealthCare LLC,
100 Bayer Boulevard, Whippany, New Jersey 07981,
US
|
(74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
(54) | Arilkarbamido junginiai derinyje su kitais citostatiniais arba citotoksiniais agentais, skirti žmonių piktybiniams navikams gydyti |
Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
Payment date | Validity (years) | Amount | |
2021-11-29 | 347.00 EUR |